Many studies had demonstrated that cFLIP is highly expressed in various human cancers, such as colorectal cancer, bladder urothelial cancer and breast cancer25–27, and the level of cFLIP expression was correlated with poor clinical outcomes. Here, CFLAR is linked to bladder transitional cell carcinoma.